A detailed history of Morgan Stanley transactions in Psychemedics Corp stock. As of the latest transaction made, Morgan Stanley holds 3,001 shares of PMD stock, worth $7,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,001
Previous 3,001 -0.0%
Holding current value
$7,022
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

SELL
$2.25 - $2.88 $1,125 - $1,440
-500 Reduced 14.28%
3,001 $7,000
Q2 2024

Aug 14, 2024

SELL
$2.25 - $2.88 $1,125 - $1,440
-500 Reduced 14.28%
3,001 $7,000
Q1 2024

Oct 17, 2024

BUY
$2.92 - $3.79 $1,460 - $1,895
500 Added 16.66%
3,501 $10,000
Q4 2023

Aug 16, 2024

BUY
$2.06 - $3.69 $1,030 - $1,845
500 Added 16.66%
3,501 $10,000
Q4 2023

Feb 13, 2024

SELL
$2.06 - $3.69 $2,057 - $3,686
-999 Reduced 22.2%
3,501 $10,000
Q3 2023

Nov 15, 2023

SELL
$3.66 - $5.05 $44,073 - $60,812
-12,042 Reduced 72.8%
4,500 $17,000
Q2 2023

Aug 14, 2023

BUY
$4.55 - $5.6 $1,237 - $1,523
272 Added 1.67%
16,542 $75,000
Q1 2023

May 15, 2023

BUY
$4.93 - $6.47 $21,761 - $28,558
4,414 Added 37.23%
16,270 $85,000
Q4 2022

Feb 14, 2023

SELL
$4.9 - $6.7 $38,592 - $52,769
-7,876 Reduced 39.91%
11,856 $58,000
Q3 2022

Nov 14, 2022

BUY
$6.08 - $6.84 $3,496 - $3,933
575 Added 3.0%
19,732 $127,000
Q2 2022

Oct 27, 2022

BUY
$6.1 - $7.04 $86,260 - $99,552
14,141 Added 281.92%
19,157 $122,000
Q2 2022

Aug 15, 2022

BUY
$6.1 - $7.04 $86,260 - $99,552
14,141 Added 281.92%
19,157 $122,000
Q1 2022

Oct 27, 2022

SELL
$6.49 - $7.56 $91,775 - $106,905
-14,141 Reduced 73.82%
5,016 $35,000
Q1 2022

May 13, 2022

BUY
$6.49 - $7.56 $25 - $30
4 Added 0.08%
5,016 $35,000
Q4 2021

Feb 14, 2022

SELL
$6.86 - $8.79 $7,998 - $10,249
-1,166 Reduced 18.87%
5,012 $35,000
Q3 2021

Nov 15, 2021

BUY
$6.31 - $8.4 $38,983 - $51,895
6,178 New
6,178 $52,000

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $13.2M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.